´ïŵÈðΤÖÎÁƳõÖκ;­ÖÎйڷÎÑ×»¼ÕßµÄÊ׸öÁÙ´²Ñо¿½á¹û·¢±í

·¢²¼Ê±¼ä£º2020-03-25 22:15:12 À´Ô´£º
Öйúº¼ÖݺÍÉÜÐË2020Äê3ÔÂ25ÈÕ / ÃÀͨÉç/ -- ¸èÀñÖÆÒ©ÓÐÏÞ¹«Ë¾£¨Ïã¸ÛÁª½»Ëù´úÂ룺1672£©½ñÈÕÐû²¼¸êŵÎÀ®£¨´ïŵÈðΤ£©ÖÎÁƳõÖκ;­ÖεÄÐÂÐ͹Ú×´²¡¶¾·ÎÑ×»¼ÕßµÄÊ׸öÁÙ´²Ñо¿½á¹ûÔÚҽѧԤӡ±¾medRxivÉÏ·¢±í£¨ÎÄÕ±êÌâΪ¡°First Clinical Study Using HCV Protease Inhibitor Danoprevir to Treat Naiveand Experienced COVID-19 Patients¡± £©¡£

¸ÃСÑù±¾ÁÙ´²Ñо¿½á¹ûÏÔʾ£¬´ïŵÈðΤÁªºÏÀûÍÐÄÇΤÖÎÁÆÔÚËùÓл¼ÕßÖеݲȫÐÔºÍÄÍÊÜÐÔÁ¼ºÃ¡£¾­¹ý4-12Ìì´ïŵÈðΤÁªºÏÀûÍÐÄÇΤÖÎÁƺó£¬Èë×éµÄ11ÀýÆÕͨÐÍÐÂÐ͹Ú×´²¡¶¾·ÎÑ×»¼Õߣ¨°üº¬2λ³õÖλ¼ÕߺÍ9λ¾­Öλ¼Õߣ©È«²¿´ïµ½ÒÔÏÂËÄÏî±ê×¼ºó³öÔº£º£¨1£©Ìåλָ´Õý³£3ÌìÒÔÉÏ£»£¨2£©ºôÎüµÀÖ¢×´Ã÷ÏÔºÃת£»£¨3£©·Î²¿Ó°ÏñѧÏÔʾ¼±ÐÔÉø³öÐÔ²¡±äÃ÷ÏÔ¸ÄÉÆ£»£¨4£©Á¬ÐøÁ½´ÎºôÎüµÀ±ê±¾ºËËá¼ì²âÒõÐÔ£¨²ÉÑùʱ¼äÖÁÉÙ¼ä¸ô1Ì죩¡£

ÔÚ¿ªÊ¼½ÓÊÜ´ïŵÈðΤÁªºÏÀûÍÐÄÇΤÖÎÁƺó£¬ËùÓл¼ÕßRT-PCR¼ì²â½á¹ûÊ״γÊÒõÐÔµÄʱ¼äÖÐλÊýΪ2Ì죬×îСֵΪ1Ì죬×î´óֵΪ8Ì죻 CTÓ°Ïñѧ½á¹ûÏÔʾ²¡ÔîÃ÷ÏÔÎüÊÕµÄʱ¼äÖÐλÊýΪ3Ì죬×îСֵΪ2Ì죬×î´óֵΪ4Ìì¡£ÁÙ´²½á¹ûÏÔʾ£¬´ïŵÈðΤÁªºÏÀûÍÐÄÇΤÓÐÍû³ÉΪÖÎÁÆÐÂÐ͹Ú×´²¡¶¾·ÎÑ×µÄÓÐЧ·½°¸¡£

¸êŵÎÀ®£¨´ïŵÈðΤ£©ÊǸèÀñÑз¢µÄ¿Ú·þ±û¸Î²¡¶¾µ°°×øÒÖÖÆ¼Á£¬ÓÚ2018Äê6Ô»ñµÃ¹ú¼ÒÒ©Æ·¼à¶½¹ÜÀí¾ÖÅú×¼ÉÏÊУ¬ÓÃÓÚÖÎÁÆÂýÐÔ±ûÐ͸ÎÑס£

¸èÀñ´´Ê¼ÈË¡¢¶­Ê³¤¼æÊ×ϯִÐйÙÎâ¾¢è÷²©Ê¿±íʾ£º¡°ºÜ¸ßÐË´ïŵÈðΤÖÎÁÆÐ¹ڷÎÑ×µÄÊ׸öÁÙ´²Ñо¿½á¹ûÔÚҽѧԤӡ±¾medRxivÉÏ·¢±í£¬Îª¿¹»÷йڷÎÑ×¹±Ï׸èÀñÁ¦Á¿¡£¡±

Ïà¹ØÈÈ´ÊËÑË÷£º
¹ØÓÚÎÒÃÇ ÁªÏµÎÒÃÇ ÈËÔ±²éѯ ÃâÔðÉùÃ÷ ÓÑÇéÁ´½Ó ¹óÖÝÍøLOGO ¹ã¸æ¿¯Àý ±¾Õ¾ÓòÃû °Ù¶ÈÐÂÎÅ